腫瘤標志 的英文怎麼說

中文拼音 [zhǒngliúbiāozhì]
腫瘤標志 英文
tumor-marker
  • : Ⅰ名詞(隆起處) swelling Ⅱ動詞(突起) swell; be swollen
  • : 名詞(瘤子) tumour
  • : Ⅰ名詞1 [書面語] (樹梢) treetop; the tip of a tree2 (枝節或表面) symptom; outside appearance; ...
  • : Ⅰ名詞1 (志向; 志願) aspiration; ambition; ideal; will 2 (文字記錄) records; annals 3 (記號)...
  • 腫瘤 : tumour; core (綿羊體內的); neoplasm; phyma
  • 標志 : signmarksymbolhallmarkblipemblemdenotationtagensignflagattributemarkerbrandstypeindex
  1. Serum concentrations of tumor markers in dialyzed and non - dialyzed patients with chronic kidney diseases

    腎功能及血液透析對慢性腎臟疾病患者血清腫瘤標志物的影響
  2. From the new point of view, looking for tumor - specific proteins with proteomics research strategy may help to elucidate the correlation of the change of protein expression to oncogenesis, and may play a vital role in the early detection of cancer and anticancer therapy including drug exploitation

    蛋白質組學從新的角度研究,尋找腫瘤標志蛋白,進而闡明其表達水平的變化與發生、發展的相互關系,對的早期診斷、治療、藥物研發等方面具有重要意義。
  3. Cea gene was transferred into human dcs, and specific anti - cancer effecs induced by the vaccine was observed. this test is part of my tutor ' s. hang you - tian has observed the induction of crcinembryonic antigen ( cea ) - specific cytotoxic t - lymphocyte responses in vitro when he transfected dcs with pcdna3 - cea, and has observed the immunity effects of the dcs ( pcea ) inoculateing against to ct 26 ( hcea + ) loaded in balb / c mice. after vaccination with the cea gene - modified dc, the survival time of the mice vaccinated with ct26 + ( cea + ) ws prolonged more potently than that of the mice vaccinatd with other dcs

    癌胚抗原( carcinoebryonicantigen , cea )是一種研廠鄭州大學2002年碩士畢業論文轉染人癌胚抗原真核表達質粒的人樹突狀細胞的抗作用究最為深入的相關抗原( tumorassociatiednigen , taa ) ,在90的胃腸道、 50的乳腺癌及70的非小細胞肺癌中有高水平的表達,是目前國際上公認的腫瘤標志物。
  4. Methods. thirty - eight candidates for lt with hepatitis c virus ( hcv ) cirrhosis and hcc were studied. gene expression ( gexp ) analysis of tumor samples was performed using microarrays

    對于小肝癌( hcc )的患者而言,肝移植是一種根治療法。由於缺乏預測進展和復發的腫瘤標志物那些有可能被治療的更高階段的肝細胞癌的患者被拒絕用肝移植療法。
  5. At present, there are many misdiagnosis or missed diagnosis in clinical therapy of thyroid neoplasms it ' s vital to find the special molecular markers to establish truly feasible examination method for the patient ' s diagnosis and the treatment

    摘要目前甲狀腺的術前診斷存在較高的誤診或漏診率,確定能鑒別良、惡性甲狀腺的特異性分子物,建立確實可行的檢測手段,對甲狀腺病人的診斷及治療具有重要意義。
  6. Aruna basu, murthy u, rodeck u, et al. presence of tumor associated antigens in epidermal growth facter receptors from different human carcinomus cancer res, 1987, 47 : 2531

    賈心善,赫明昌,張麗紅,等. 145例肺癌患者及癌旁組織癌胚抗原的記研究.中華病理學雜, 1988 , 17 : 173
  7. Identification of tumor markers with silac proteomics approaches

    細胞培養穩定同位素記技術與腫瘤標志分子研究
  8. Clinical application of combining tumor markers in diagnosis of lung cancer

    血清腫瘤標志物聯合檢測在肺癌診斷中的應用
  9. Cea is probably the most extensively characterized human tumor associated antigen. it was discovered in colorectal and pancreatic carcinomas in 1965 and it " s full cdna was cloned in 1987. it is a kind of glycoprotein and it " s molecular weight is 180kd

    癌胚抗原( carcinoembryonicantigencea )是一種最常見的相關抗原( taa ) ,也是國際上公認的腫瘤標志物,於1965年首次在人結腸癌和胰腺癌中發現, 1987年克隆出它的全長基因序列。
  10. Mark product introduction of tumour

    腫瘤標志物產品介紹
  11. Clinical value of multiple tumor markers protein biochip detective system for malignant tumor

    多種腫瘤標志物蛋白晶元檢測系統對惡性的臨床應用價值
  12. Clinical value of multi - tumor markers detection with cea, ca19 - 9, ca72 - 4 for diagnosis of gastric malignancy

    多項腫瘤標志物聯檢對胃惡性診斷的臨床價值
  13. This article summarizes relations between tumor markers and the thyroid neoplasms and its the potential clinical significance research progress

    作者綜述腫瘤標志物與甲狀腺的關系及其潛在臨床意義的研究進展。
  14. Preinvasive liver cancer : the alteration of tumor serum indication levels and its relationship with dialectic classification in traditional chinese medicine

    原發性肝癌血清腫瘤標志物水平的變化與中醫辨證分型的關系研究
  15. Purpose : to update the recommendations for the use of tumor marker tests in the prevention, screening, treatment, and surveillance of breast cancer

    目的:更新在乳腺癌的預防,篩查,治療和監視中的腫瘤標志物使用推薦。
  16. Telomerase is a new target of oncotherapy, the growth of tumor could be repressed by restraining telomerase activation

    端粒酶已成為新的腫瘤標志物及治療的新靶點,抑制細胞端粒酶活性可望達到抑制生長的目的。
  17. Early symptoms and physical signs of pancreatic cancer is not special and the early diagnosis rate is yet not high with auxiliary examinations and tumor markers now

    摘要胰腺癌的早期癥狀和體征多無特異性,現有的輔助檢查及腫瘤標志物並未能使胰腺癌的早期診斷率大幅度提高。
  18. Reviewing articles before, the authors try to evaluate the status and progression in early diagnosis of pancreatic cancer from epidemiology, imgeology and tumor markers in this article

    復習相關資料,就流行病學,影像學和腫瘤標志物三方面來評價目前胰腺癌早期診斷的現狀及進展作一綜述。
  19. The study, which reviewed 1, 469 women who received the med between 2001 and 2005 and was published in the journal of clinical oncology, found that some clinicians had ignored the warning labels altogether

    這項發表在臨床學雜的對1 , 469名在2001至2005間接受這種藥物治療的婦女進行的回顧性研究發現,一些臨床醫師完全忽略了簽上的警告。
  20. Their findings, published in the journal nature, support the idea that future cancer treatments will have to home in on cancer stem cells

    他們的發現發表在《自然》雜上,表明幹細胞將成為癌癥治療的靶
分享友人